WWW - Posts tagged Celgene Corp. at BloggingStocks

Celgene Corp. posts

Celgene Remains in an Uptrend

Posted Dec 21st 2009 5:00PM by Joseph Lazzaro (RSS feed)
Filed under: Stocks to Buy

Celgene Corp.'s (CELG) stock has encountered resistance at $58, but I'm nevertheless reiterating my buy rating for the company's shares, first recommended on June 19, 2009, at a price of $46.94. Here's why:

Look for Celgene's FY2010 revenue to increase 20-23%, on top of a likely a 15-20% rise in FY2009, boosted by cancer treatments Revlimid's and Vidaza's sales. Further, pipeline candidates to treat psoriasis and small cell lung cancer are approaching late-stage study.

Continue reading Celgene Remains in an Uptrend

Celgene is poised to break-out to the upside

Posted Oct 9th 2009 3:00PM by Joseph Lazzaro (RSS feed)
Filed under: Stocks to Buy

Celgene (NASDAQ: CELG), is performing as expected, hence I'm Reiterating my Buy rating for company, first recommended on June 19, 2009 at a price of $46.94. If you bought CELG in June, you're up about 20%.

Look for a 15-20% FY2009 revenue increase in CELG, boosted by cancer treatments Revlimid's and Vidaza's sales. Further, pipeline candidates to treat psoriasis and small cell lung cancer are approaching late-stage study.

Continue reading Celgene is poised to break-out to the upside